These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8677658)

  • 1. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)].
    Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
    Wien Klin Wochenschr; 1996; 108(1):20-3. PubMed ID: 8677658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
    Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
    Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
    Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of intravascular molecular weight of hydroxyethyl starch on platelets.
    Treib J; Haass A; Pindur G; Treib W; Wenzel E; Schimrigk K
    Eur J Haematol; 1996 Mar; 56(3):168-72. PubMed ID: 8598237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Acta Anaesthesiol Taiwan; 2009 Jun; 47(2):71-8. PubMed ID: 19527967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W; Pölz W; Colombo T; Steindorfer P
    Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
    Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F; Waldhausen P; Spitzer S; Wenzel E
    Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies.
    Jones PA; Tomasic M; Gentry PA
    Am J Vet Res; 1997 May; 58(5):541-8. PubMed ID: 9140565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in blood coagulation in treatment with hydroxyethyl starch].
    Sefrin P; Rauch S; Zieglmeyer C
    Anaesthesiol Reanim; 1998; 23(6):149-56. PubMed ID: 10036794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
    Asskali F; Förster H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation disorders caused by hydroxyethyl starch.
    Treib J; Haass A; Pindur G
    Thromb Haemost; 1997 Sep; 78(3):974-83. PubMed ID: 9308738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.
    Thaler U; Deusch E; Kozek-Langenecker SA
    Anaesthesia; 2005 Jun; 60(6):554-9. PubMed ID: 15918826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein.
    Chen G; Yan M; Lu QH; Gong M
    Acta Anaesthesiol Scand; 2006 Oct; 50(9):1089-94. PubMed ID: 16987338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects.
    de Jonge E; Levi M; Büller HR; Berends F; Kesecioglu J
    Intensive Care Med; 2001 Nov; 27(11):1825-9. PubMed ID: 11810130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood volume replacement and hemodilution with hydroxyethyl starch].
    Messmer K; Jesch F
    Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
    Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
    Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension].
    Heilmann L; Lorch E; Hojnacki B; Müntefering H; Förster H
    Infusionstherapie; 1991 Oct; 18(5):236-43. PubMed ID: 1722779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.